Literature DB >> 27417167

Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial.

Patricia M Kluding, J Robinson Singleton, Mamatha Pasnoor, Mazen M Dimachkie, Richard J Barohn, A Gordon Smith, Robin L Marcus.   

Abstract

Background: Half of all patients with diabetes develop diabetic peripheral neuropathy (DPN), a complication leading to reduced mobility and quality of life. Although there are no proven pharmacologic approaches to reduce DPN risk or slow its progression, evidence suggests that physical activity may improve symptoms and enhance peripheral nerve regeneration. Objective: The aim of the study will be to determine the impact of an intense lifestyle intervention on neuropathy progression and quality of life in individuals with DPN. Design: The study will be a randomized controlled trial. Setting: The study will be conducted at 2 academic medical centers. Participants: The participants will be 140 individuals with type 2 diabetes and mild to moderate DPN. Intervention: The intervention group will receive 18 months of supervised exercise training, actigraphy-based counseling to reduce sedentary behavior, and individualized dietary counseling. Control group participants will receive diet and activity counseling at baseline and at 9 months. Measurements: The primary outcomes are neuropathy progression as measured by intraepidermal nerve fiber density in a distal thigh skin biopsy and the Norfolk Quality of Life-Diabetic Neuropathy score. Secondary outcomes include pain, gait, balance, and mobility measures. Limitations: Due to the combined intervention approach, this protocol will not be able to determine which intervention components influence outcomes. There also may be difficulty with participant attrition during the 18-month study intervention. Conclusions: The Activity for Diabetic Polyneuropathy (ADAPT) protocol resulted from a collaboration between physical therapists and neurologist researchers that includes as primary outcomes both a quality-of-life measure (NQOL-DN) and a physiologic biomarker (IENFD). It has the potential to demonstrate that an intensive lifestyle intervention may be a sustainable, clinically effective approach for people with DPN that improves patient outcomes and can have an immediate impact on patient care and future clinical trials.
© 2017 American Physical Therapy Association

Entities:  

Mesh:

Year:  2017        PMID: 27417167      PMCID: PMC6257067          DOI: 10.2522/ptj.20160200

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  56 in total

1.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.

Authors:  Diane C Zelman; Mugdha Gore; Ellen Dukes; Kei-Sing Tai; Nancy Brandenburg
Journal:  J Pain Symptom Manage       Date:  2005-04       Impact factor: 3.612

4.  Fall and balance outcomes after an intervention to promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: "feet first" randomized controlled trial.

Authors:  Robin L Kruse; Joseph W Lemaster; Richard W Madsen
Journal:  Phys Ther       Date:  2010-08-26

5.  Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial.

Authors:  Ronald J Sigal; Glen P Kenny; Normand G Boulé; George A Wells; Denis Prud'homme; Michelle Fortier; Robert D Reid; Heather Tulloch; Douglas Coyle; Penny Phillips; Alison Jennings; James Jaffey
Journal:  Ann Intern Med       Date:  2007-09-18       Impact factor: 25.391

6.  Diagnostic accuracy of fall risk assessment tools in people with diabetic peripheral neuropathy.

Authors:  Stephen D Jernigan; Patricia S Pohl; Jonathan D Mahnken; Patricia M Kluding
Journal:  Phys Ther       Date:  2012-07-26

Review 7.  Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms.

Authors:  Douglas W Zochodne
Journal:  Muscle Nerve       Date:  2007-08       Impact factor: 3.217

8.  Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.

Authors:  Rodica Pop-Busui; Jiang Lu; Neuza Lopes; Teresa L Z Jones
Journal:  J Peripher Nerv Syst       Date:  2009-03       Impact factor: 3.494

Review 9.  Interventions with potential to reduce sedentary time in adults: systematic review and meta-analysis.

Authors:  Anne Martin; Claire Fitzsimons; Ruth Jepson; David H Saunders; Hidde P van der Ploeg; Pedro J Teixeira; Cindy M Gray; Nanette Mutrie
Journal:  Br J Sports Med       Date:  2015-04-23       Impact factor: 13.800

10.  Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus.

Authors:  Amanda L Boyd; Patricia M Barlow; Gary L Pittenger; Kathryn F Simmons; Aaron I Vinik
Journal:  Diabetes Metab Syndr Obes       Date:  2010-12-06       Impact factor: 3.168

View more
  5 in total

Review 1.  Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders.

Authors:  Jeremy Chung Bo Chiang; Ria Arnold; Roshan Dhanapalaratnam; Maria Markoulli; Arun V Krishnan
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-15

Review 2.  Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy.

Authors:  Amro M Stino; Amy E Rumora; Bhumsoo Kim; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2020-06       Impact factor: 3.494

3.  Interventions for promoting physical activity in people with neuromuscular disease.

Authors:  Katherine Jones; Fiona Hawke; Jane Newman; James Al Miller; Joshua Burns; Djordje G Jakovljevic; Grainne Gorman; Douglass M Turnbull; Gita Ramdharry
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

Review 4.  Peripheral neuropathy in prediabetes and the metabolic syndrome.

Authors:  Amro M Stino; Albert G Smith
Journal:  J Diabetes Investig       Date:  2017-05-03       Impact factor: 4.232

Review 5.  The Role of New Technological Opportunities and the Need to Evaluate the Activities Performed in the Prevention of Diabetic Foot with Exercise Therapy.

Authors:  Piergiorgio Francia; Alessandra De Bellis; Giulia Iannone; Rosy Sinopoli; Leonardo Bocchi; Roberto Anichini
Journal:  Medicines (Basel)       Date:  2021-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.